For example, the PDE4 inhibitors Chlorbipram [325] and GSK356278 [267] were demonstrated to show equal or significantly enhanced brain penetrance when compared to Rolipram, respectively, using models of anti-anxiety or anti-depression, without the induction of emesis. This evidence concerns the gene PDE4A and depressive disorder.